The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Planned safety analysis of the ACTS-CC 02 trial: A randomized phase III trial of S-1/oxaliplatin (SOX) versus UFT/LV as adjuvant chemotherapy for high-risk stage III colon cancer.
 
Takuya Miura
Travel, Accommodations, Expenses - Taiho Pharmaceutical
 
Eiji Sunami
No Relationships to Disclose
 
Tetsuya Kusumoto
No Relationships to Disclose
 
Mitsuyoshi Ota
No Relationships to Disclose
 
Kazuhiro Yoshida
Honoraria - Chugai Pharma; Pfizer; Taiho Pharmaceutical; Yakult Honsha
 
Naohiro Tomita
No Relationships to Disclose
 
Atsuyuki Maeda
No Relationships to Disclose
 
Izumi Mochizuki
No Relationships to Disclose
 
Michio Okabe
No Relationships to Disclose
 
Katsuyuki Kunieda
No Relationships to Disclose
 
Junichiro Yamauchi
No Relationships to Disclose
 
Michio Itabashi
No Relationships to Disclose
 
Kenjiro Kotake
Honoraria - Bayer Yakuhin; Bristol-Myers Squibb; Chugai Pharma; Taiho Pharmaceutical; Yakult Honsha
 
Keiichi Takahashi
Honoraria - Chugai Pharma; Taiho Pharmaceutical; Takeda
 
Hideo Baba
Honoraria - Taiho Pharmaceutical
Research Funding - Taiho Pharmaceutical (Inst)
 
Narikazu Boku
Honoraria - Chugai Pharma; Daiichi Sankyo; Lilly Japan; Merck Serono; Ono Pharmaceutical; Shionogi; Taiho Pharmaceutical; Takeda; Yakult Honsha
Research Funding - Chugai Pharma (Inst); Taiho Pharmaceutical (Inst)
 
Keisuke Aiba
No Relationships to Disclose
 
Megumi Ishiguro
Honoraria - Chugai Pharma; Taiho Pharmaceutical; Yakult Honsha
Consulting or Advisory Role - Taiho Pharmaceutical
Research Funding - Taiho Pharmaceutical; Yakult Honsha
 
Satoshi Morita
Honoraria - Taiho Pharmaceutical
Consulting or Advisory Role - Taiho Pharmaceutical
 
Kenichi Sugihara
Honoraria - Chugai Pharma; Taiho Pharmaceutical
Research Funding - Chugai Pharma; Taiho Pharmaceutical